āagman

Not investment advice. Data and computed figures, for information only.

Shilpa Medicare Ltd

NSE: SHILPAMED
₹922.10
−₹40.00 (−4.16%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹19,983 Cr
CMP
₹922.10
52-wk High / Low
₹1,095 / 260
P/E
70.3
P/B
7.7
Book Value
₹132.0
Div Yield
0.06%
ROCE
11.0%
ROE
9.0%
Face Value
₹1
D/E
0.25

Price+151.4% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 13 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
6
/ 9
6 of 9 F-score tests passed
Graham Number
₹192
√(22.5 × EPS × book value per share)
ROIC
8.0%
vs 11.2% sector median
Cash flow to profit
1.41
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+84
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
8.6%
ROE × earnings retention ratio
ROE stability
3.6
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +1.04DII −0.32
Latest quarter vs the previous one
Cash-accrual divergence
−2.8%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.7x)
Watch-outs
−Latest ROCE of 11% trails the sector median of 17%
−Borrowings are up 198.6% since FY2016 (221 to 660)
−Promoter holding fell by 9.9pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales260313287292293344319331321370410437466
Expenses214255222222222258239252231262296317330
Operating Profit465865707086817991108114120136
OPM %17.7%18.5%22.6%24.0%23.9%25.0%25.4%23.9%28.3%29.2%27.8%27.5%29.2%
Other Income22291052−2162−13459
Interest18232624242612141916111412
Depreciation27282727272829292930303135
Profit before tax3914282937421550646112098
Net Profit1252414183215474445108101
EPS (₹)0.070.090.261.410.720.921.620.742.402.252.285.515.16

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6147197797897339088991,1411,0461,1461,2811,5351,683
Expenses4855666146345856887189409479079621,1001,204
Operating Profit12915316515514821918120299239319435479
OPM %21.0%21.3%21.2%19.6%20.2%24.1%20.1%17.7%9.5%20.9%24.9%28.3%28.5%
Other Income551522331790211715−83943
Interest47334522415992765952
Depreciation212931374244548096108113120126
Profit before tax108122146137136188195102−3854122295344
Net Profit739910410311015514661−313278243297
EPS (₹)4.786.736.716.456.889.579.063.49−1.871.844.0012.4415.20

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital88888889991020—
Reserves5396399791,0771,1891,3211,4711,8141,7751,8002,3532,572—
Borrowings189221241191194390846683798937588660—
Other Liabilities169194244223218270308370323347360455—
Total Liabilities9051,0621,4721,4991,6101,9892,6322,8762,9043,0933,3113,706—
Fixed Assets3165804925345586501,1111,3421,3681,3851,4181,593—
CWIP22295141210429666541506655719822884—
Investments6653253140210213443403558—
Other Assets3013345876156216629599938389501,0371,170—
Total Assets9051,0621,4721,4991,6101,9892,6322,8762,9043,0933,3113,706—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity69129374514712447105180137132342
Cash from Investing Activity−196−106−257−10−196−290−404−286−232−171−198−339
Cash from Financing Activity136−20313−61101764368346476314
Net Cash Flow9393−26−391079−98−713−317

Ratios

As of 31 Mar 2026
12 periods
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %18.016.014.010.09.012.08.06.01.05.08.011.0
ROE %———————————9.0
EPS (₹)4.786.736.716.456.889.579.063.49−1.871.844.0012.44
Book Value (₹)———————————132.0
Face Value (₹)———————————1
P/E———————————70.3
Div Yield %———————————0.06
NPM %11.813.713.112.714.416.814.85.2−2.92.86.115.4
OPM %21.021.021.020.020.024.020.018.09.021.025.028.0
D/E0.350.340.240.180.160.290.570.370.450.520.250.25
P/B———————————7.7

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+8.0%
5 years+11.0%
3 years+14.0%
TTM+28.0%
Compounded profit growth
10 years+8.0%
5 years+17.0%
3 years+107.0%
TTM+117.0%
Stock price CAGR
10 years+14.0%
5 years+27.0%
3 years+81.0%
Last year+179.0%
Return on equity
10 years6.0%
5 years4.0%
3 years5.0%
Last year9.0%

Shareholding pattern

As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters54.74%54.74%54.74%53.80%53.80%53.80%53.25%50.01%50.01%50.01%44.23%40.13%40.13%
FIIs25.98%25.98%25.98%18.80%19.05%19.09%16.23%14.41%13.73%5.63%10.97%11.07%12.11%
DIIs5.58%5.58%5.58%13.11%7.52%7.84%4.41%1.93%0.54%1.65%7.55%8.58%8.26%
Government—————————————
Public13.70%13.70%13.70%14.29%19.63%19.26%26.12%33.65%35.72%42.71%37.25%40.21%39.49%
No. of shareholders14,39614,39614,39616,40916,54614,92551,27739,72446,86946,04650,10853,41087,477
Change since Jun 2023 (pp)
Promoters −14.61FIIs −13.87DIIs +2.68Public +25.79

Documents

As of 11 Oct 2026
Announcements
Europe GMP Approval Of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Closure of Trading WindowIntimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Assignment Of ESG Rating By CRISIL ESG Ratings.
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingFeb 2026PPTNov 2025TranscriptNov 2025PPT

Corporate actions

As of 4 Sep 2026
4 Sep 2026DIVIDENDDividend - Re 0.60 Per Share—
3 Oct 2025BONUSBonus 1:1—
17 Sep 2025DIVIDENDDividend - Re 1 Per Share—
19 Sep 2022DIVIDENDAnnual General Meeting/Dividend - Rs 1.10 Per Share—
20 Sep 2021DIVIDEND Dividend - Rs 1.10 Per Share—
16 Mar 2020DIVIDEND Interim Dividend - Rs 1.10 Per Share—
12 Sep 2019DIVIDEND Annual General Meeting/Dividend - Rs 1 Per Share—
1 Mar 2018DIVIDEND Interim Dividend Re 0.70 Per Share (Purpose Revised)—
21 Mar 2017DIVIDEND Interim Dividend Re 0.60 Per Share—
28 Mar 2016DIVIDEND Interim Dividend - Re 0.60/- Per Share (Purpose Revised)—
6 Nov 2015SPLIT Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share2 : 1
16 Sep 2015DIVIDEND Annual General Meeting/ Dividend - Rs 1.10/- Per Share—
11 Sep 2014DIVIDENDAnnual General Meeting / Dividend - Re 1/- Per Share—
16 Jul 2013BONUSAnnual General Meeting / Dividend - Rs 1.30/- Per Share / Bonus 1:2—
17 Sep 2012DIVIDENDAnnual General Meeting And Dividend Re.0.90 Per Share—
15 Sep 2011DIVIDENDAnnual General Meeting And Dividend - Rs.0.80 Per Share—
16 Sep 2010DIVIDENDAnnual General Meeting And Dividend Re.0.70 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman